Cigna Group
For the period ended Sep 30, 2025. Filed Oct 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
The following table provides information about The Cigna Group share repurchase activity for the quarter ended September 30, 2025:
| Period | Total # of shares purchased (1) | Average price paid per share (1) (3) | Total # of shares purchased as part ofpublicly announced program (2) | Approximate dollar value of sharesthat may yet be purchased as partof publicly announced program (3) (in millions) |
|---|---|---|---|---|
| July 1 - 31, 2025 | 1,109 | $304.07 | — | $7,732 |
| August 1 - 31, 2025 | 2,402 | $299.23 | — | $7,732 |
| September 1 - 30, 2025 | 2,989 | $290.74 | — | $7,732 |
| Total | 6,500 | $296.15 | — | N/A |
(1)Includes shares tendered by employees under the Company's equity compensation plans as follows: 1) payment of taxes on vesting of restricted stock (grants and units) and strategic performance shares and 2) payment of the exercise price and taxes for certain stock options exercised. Employees tendered 1,109 shares in July, 2,402 shares in August and 2,989 shares in September 2025.
(2)Additionally, the Company maintains a share repurchase program authorized by the Board. Under this program, the Company may repurchase shares from time to time, depending on market conditions and alternate uses of capital. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. The share repurchase program may be effected through Rule 10b5-1 plans, open market purchases, each in compliance with Rule 10b-18 under the Exchange Act, or privately negotiated transactions. The program may be suspended or discontinued at any time and does not have an expiration date.
(3)The average price paid per share and approximate dollar value of shares exclude the impact of excise tax.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.